Laminin β4 (lamβ4) has been identified as a novel target antigen in anti-p200 pemphigoid, a rare autoimmune disease manifesting with subepidermal blisters. Anti-lamβ4 antibodies bind to the region of the dermal–epidermal junction and demonstrate pathogenic effects. A recombinant-cell indirect immunofluorescence assay has been developed for specific detection of anti-lamβ4 antibodies.
A groundbreaking customizable immunoassay system developed by Japanese researchers offers rapid detection of disease biomarkers, allergens and other biomolecules with exceptional sensitivity, potentially revolutionising point-of-care diagnostics
A recent report published by the Food Standards Agency in the UK [Patterns and prevalence of adult food allergy (PAFA); https://shorturl.at/jnaLY] estimates that around 6% of the UK adult population have a clinically confirmed IgE-mediated food allergy.
By Dr Jacqueline Gosink New American College of Rheumatology and European Alliance of Associations for Rheumatology classification criteria for antiphospholipid syndrome have been developed to aid cohort selection for research and clinical trials. The classification system includes both clinical and laboratory criteria, which are hierarchically clustered, weighted and risk-stratified to ensure high specificity.
Munich-based biopharmaceutical company SciRhom GmbH has secured a substantial €63 million (US$70 million) in Series A financing to accelerate the development of its pioneering iRhom2-targeting antibodies for autoimmune disorders. The oversubscribed funding round, co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, will propel the company’s lead candidate toward clinical proof-of-concept […]
A unique portfolio of neurobiomarker tests The testing landscape for neurological diseases has expanded rapidly in recent years due to the characterisation of many novel biomarkers. With over 15 years of experience in neurological analytics, EUROIMMUN offers an unparalleled portfolio of assays for determination of more than 80 neurobiomarkers in autoimmune diseases, neurological infections and […]
The EUROLINE portfolio for autoimmune liver diseases (AILD) has been extended with the antigen F-actin and now features the DL 1300-9G with 10 antigens for the determination of AILD-related autoantibodies.
The EUROLINE Autoimmune Inflammatory Myopathies Profile has been expanded and now includes 20 antigens for detection and differentiation of autoantibodies that occur in idiopathic inflammatory myopathies (IIM).
EUROIMMUN has been creating innovative solutions for immunofluorescence diagnostics for over thirty years. Continuing this long tradition, the company has over the last year introduced further groundbreaking products to increase the efficiency and standardization of indirect immunofluorescence assay (IFA) analyses. CLI talked to Dr Panagiotis Grypiotis, Head of Product Management Autoimmune Diagnostics, Endocrinology/Biologics and Automation […]
by Dr Petraki Munujos Systemic vasculitides are a group of inflammatory idiopathic clinical syndromes usually classified by the size of the vessels being affected. Among them, the small vessels vasculitides show clear associations with the presence in the patients sera of antibodies directed against cytoplasmic antigens of neutrophils (ANCA).
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.